Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Moderna Inc (NQ: MRNA )

107.57 +3.11 (+2.98%)
Streaming Delayed Price Updated: 11:20 AM EDT, Apr 23, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Moderna Inc

< Previous 1 2
...
28 29 30 31 32 33 34 35 36
...
99 100 Next >
3 Top Stocks to Buy Before 2023
Here are some great bargains for long-term investors as we approach the end of the year. 
Via The Motley Fool
10 Health Care Stocks Whale Activity In Today's Session
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity... 
Via Benzinga
Market Rally Pressured On Fed Rate Outlook; Moderna, Boeing, Tesla In Focus: Weekly Review
Moderna spiked on a cancer vaccine while Tesla continued to dive. 
Via Investor's Business Daily
Why Is Novavax (NVAX) Stock Down 10% Today?
Novavax is conducting a public offering of 6.5 million shares. Here's why the news is pushing NVAX stock down. 
Via InvestorPlace
What 8 Analyst Ratings Have To Say About Moderna
Via Benzinga
Why Moderna Stock Is Popping Over 20% Today
Moderna Stock is ripping higher today after a cancer treatment breakthrough. Is Moderna stock a buy now? 
Via The Motley Fool
Why Moderna Stock Is Skyrocketing Today
Moderna's personalized cancer vaccine program just received a big boost. 
Via The Motley Fool
2 Biotech Stocks to Buy Hand Over Fist in 2023 and 1 to Avoid Like the Plague
Two drug developers stand out as plain-as-day bargains in the new year, while another top-performing biotech stock looks poised to disappoint. 
Via The Motley Fool
BioNTech Stock Gets Upgrade, Analyst Sees Multiple Upside Opportunities
Via Benzinga
3 Growth Stocks With More Potential Than Any Cryptocurrency
If the crypto meltdown has you discouraged, don't give up on stocks. 
Via The Motley Fool
Why Is Novavax (NVAX) Stock Plunging Today?
NVAX stock is down today on fundraising plans. Here's what investors should know about this once-promising Covid-19 vaccine player. 
Via InvestorPlace
Is Moderna a Good Stock to Buy Right Now?
Recent results suggest the company's cancer vaccine candidate can succeed where others have failed. 
Via The Motley Fool
Moderna Stock Shows Surprising Strength; Key Rating Upgraded
See if Moderna stock forms a new pattern or follow-on buying opportunity like a three-weeks tight or pullback to the 50-day average. 
Via Investor's Business Daily
7 Stocks to Buy on the Dip as the S&P 500 Falters
Investors looking for a margin of safety and growth even in a recession should consider these cheap stocks to buy on the dip. 
Via InvestorPlace
10 Health Care Stocks Whale Activity In Today's Session
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity... 
Via Benzinga
Most Active Equity Options For Midday - Wednesday, Dec. 14
Here are the most active equity options for midday. 
Via Talk Markets
Why Moderna Shares Are Rising Again Today
Moderna Inc (NASDAQ: MRNA) shares are trading higher by 8.5% to $214.34 on continued upward momentum after the company and Merck announced mRNA-4157/V940 in combination with KEYTRUDA, met the primary... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 14, 2022
Via Benzinga
Is Moderna Stock a Buy After Its Impressive Cancer Vaccine Results?
Moderna could have a winner with its personalized cancer vaccine. But the company also faces big questions. 
Via The Motley Fool
Tesla, Amazon, Coinbase, Moderna, Nuwellis: Why These 5 Stocks Are Drawing Investors' Attention Today
Major Wall Street indices closed in the green on Tuesday after consumer price inflation at 7.1% for November came in lower than expected. 
Via Benzinga
Moderna Soars On Cancer Vaccine News: Here's What To Watch Going Forward
Moderna, Inc (NASDAQ: MRNA) gapped up 13% to start the trading day on Tuesday and was skyrocketing an additional 12% intraday after announcing that its Merck & Co, Inc (NYSE: MRK) partnered cancer 
Via Benzinga
Moderna's Data From Personalized Cancer Vaccine Provides Relief To Investors, Analyst Says
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
Cooling Inflation In Focus, Stocks Maintain Strong Gains
Stocks are maintaining strong leads this afternoon, after blowing out of the gates earlier on the heels of a cooler-than-expected consumer price index (CPI) for November. 
Via Talk Markets
Why OpGen Shares Are Trading Higher By 220%? Here Are 64 Stocks Moving In Tuesday's Mid-Day Session
Gainers OpGen, Inc. (NASDAQ: OPGN) shares surged 220% to $0.3994 after the company announced topline data from its Unyvero urinary tract infections (UTI) clinical trial. 
Via Benzinga
Dear First Solar (FSLR) Stock Fans, Mark Your Calendars for Dec. 19
First Solar (FSLR) stock is rising higher on Tuesday as investors prepare for a potential major catalyst coming on Dec. 19. 
Via InvestorPlace
2 Pandemic Stocks That Could Make You Richer in 2023 and Beyond
These companies can continue growing long after the pandemic ends. 
Via The Motley Fool
United Airlines Just Bought 100 Boeing Dreamliners. BA Stock Is Rising.
Boeing (BA) stock is on the move Tuesday as investors react to a massive deal between it and United Airlines (UAL) for 787 Dreamliners. 
Via InvestorPlace
2 Nasdaq Stocks Taking Big Strides Forward
As markets soar following a healthy inflation report, investors are watching these two companies closely. 
Via The Motley Fool
Moderna (MRNA) Stock Soars on Cancer Vaccine News
Moderna (MRNA) stock is rising higher on Tuesday following the release of data from a Phase 2B cancer vaccine clinical trial. 
Via InvestorPlace
< Previous 1 2
...
28 29 30 31 32 33 34 35 36
...
99 100 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.